• About Us
    About UsNewsExecutive SummaryPartners
  • Covid-19 Insights
  • Platform
  • Solutions
  • Products
    HealthNexus™ ReportsHealthNexus™HealthNexus™ Streams API
  • Resources
    Knowledge CenterSupport
  • Sign In
Our Solutions

Get Started Today

Get access in minutes. Gain insights instantly.

REQUEST A FREE TRIAL

PurpleLab

What provider profiling problems can we help you with? Let us know.


Recent Insights

Access published evidence and customer use cases

National Patient Safety Efforts Save 125,000 Lives and Nearly $28 Billion in Costs National Patient Safety Efforts Save 125,000 Lives and Nearly $28 Billion in Costs
Multiple studies confirm that Medicare’s payment reduction policies for complications has not resulted in reductions in complications. Multiple studies confirm that Medicare’s payment reduction policies for complications has not resulted in reductions in complications.
Life science innovations need to be diffused into the healthcare marketplace. For these reasons, life science companies hire direct and distributor–based sales forces and undertake marketing programs such as speaker programs. HCPs are most typically identified by life science companies through the use of retail-based prescription volume data that provides volumetric information by total TRx) and new start (“NRx”) prescriptions. These data sets mask institutionally focused HCPs, whereas medical claims data readily identifies high volume institutionally focused HCPs based on diagnosis and procedure volumes. Life science companies should consider using medical claims data to profile HCPs for sales and marketing effectiveness and efficiency. Life science innovations need to be diffused into the healthcare marketplace. For these reasons, life science companies hire direct and distributor–based sales forces and undertake marketing programs such as speaker programs. HCPs are most typically identified by life science companies through the use of retail-based prescription volume data that provides volumetric information by total TRx) and new start (“NRx”) prescriptions. These data sets mask institutionally focused HCPs, whereas medical claims data readily identifies high volume institutionally focused HCPs based on diagnosis and procedure volumes. Life science companies should consider using medical claims data to profile HCPs for sales and marketing effectiveness and efficiency.
PurpleLab identified HCOs other than those previously identified by the Department of Justice who appear to have violated the National Coverage Determinations (NCDs) establish by Medicare regarding the appropriate use and billing/reimbursement for Implantable Cardioverter Defibrillators (ICDs). PurpleLab identified HCOs other than those previously identified by the Department of Justice who appear to have violated the National Coverage Determinations (NCDs) establish by Medicare regarding the appropriate use and billing/reimbursement for Implantable Cardioverter Defibrillators (ICDs).
Studies demonstrate an inverse relation between volumes of surgical procedures performed in hospitals and related mortality. Studies demonstrate an inverse relation between volumes of surgical procedures performed in hospitals and related mortality.
Why Not The Best? How About The Worst? In Measuring Preventable Mortality Among 19 Industrialized Nations, U.S. Ranks “Dead Last”! Why Not The Best? How About The Worst? In Measuring Preventable Mortality Among 19 Industrialized Nations, U.S. Ranks “Dead Last”!
Relationship between surgeon volume and outcomes: a systematic review of systematic reviews Relationship between surgeon volume and outcomes: a systematic review of systematic reviews

Contact Us

PurpleLab, Inc.

Address

3503 York Road,

Suite 7

Furlong PA 18925

Email

info@purplelab.com

Phone

(484) 263-9982

Access in minutes. Insights instantly.

Privacy Policy | Terms | © Copyright 2020.

DO NOT SELL MY INFO
LEARN ABOUT MOBILE DEVICE OPT OUTS
Icon-linkedin Twitter Youtube